Delivery Order SPE2DB20D3103-SPE2DB25FP5J2

Award Date 7/16/25
Potential Completion Date 7/17/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,362.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, with an ID of SPE2DB20D3101|SPE2DB23FQZT4, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,203.92 firm fixed-price delivery order is for the supply of 4559561734 - AMLODIPINE-BENAZEPRIL 10-40 MG 100S, a cardiovascular medication. The contract has an ultimate completion date of January 11, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,101.54 firm fixed-price delivery order contract is for the supply of AMLODIPINE-OLMESARTAN 10-40 MG 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D2200|SPE2DB25FV89A) valued at $1,005.90 for the supply of AMLODIPINE-BENAZEPRIL 10-20 MG 100S medication. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 23, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.00 delivery order contract is for the supply of AMLODIPINE-OLMESARTAN 5-20 MG 30S, a cardiovascular medication. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through January 2024, with no set-aside designation. Amerisourcebergen maintains a $999,999,999 IDC with the DLA...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,760.72 and an ultimate completion date of February 26, 2025. It covers the supply of AMLODIPINE-BENAZEPRIL 10-40 MG 100S, a cardiovascular medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical...
This federal contract award is for the delivery of 4,565,964,777 units of the pharmaceutical product Amlodipine-Valsartan 10-160 mg, with a ceiling value of $1,270.76. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 30, 2024. The contract does not have a set-aside designation. As a large...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Amlodipine-Benazepril 10-20 mg medication in 100-count bottles. The contract has a ceiling value of $1,358.97 and a completion date of November 13, 2024. It is a firm-fixed-price contract and was not set aside for any specific business category. The award is likely part of a larger Indefinite Delivery...
This federal contract award is for the delivery of AMLOD-VALSA-HCTZ 10-160-12.5MG 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $2,053.63 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract has a completion date of July 10, 2024 and does not have a set-aside designation. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,551.21 firm fixed-price delivery order is for the supply of AMLOD-VALSA-HCTZ 10-160-25 MG 30S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP5J2
    Delivery Order

This federal contract award is for the delivery of AMLODIPINE-BENAZEPRIL 10-40 MG 100S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $1,083.84 under a firm fixed price delivery order. The award is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for the agency. This contract award is part of the DLA's efforts to establish new Pharmaceutical Prime Vendor Global Program Generation V contracts to support military healthcare programs worldwide.

Generated 10/15/25, 9:44 AM